ClinicalTrials.Veeva

Menu

Effect of CGF on Postoperative Pain After Third Molar Surgery

E

Ege University

Status

Completed

Conditions

Oral Complication

Treatments

Other: Concentrated Growth Factor
Other: non-CGF

Study type

Interventional

Funder types

Other

Identifiers

NCT06918327
EGE-DHF-MZ-002

Details and patient eligibility

About

The purpose of this study is to evaluate the effects of concentrated growth factor (CGF) on pain after bilateral impacted third molar surgery and to determine its contribution to the healing process.

The main question it aims to answer is:

Is CGF effective on reducing the pain in impacted third molar surgery? Researchers compare the pain on the CGF-applied and CGF free sides after impacted third molar surgery. Postoperative pain is assessed using the Visual Analogue Scale. TThe postoperative outcomes including pain are clinically assessed at different-time intervals (1-7 days).

Enrollment

49 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with bilateral, symmetrical, bone-retained (vertical, mesioangular, horizontal) impacted wisdom teeth in the mandible, regardless of gender
  • Patients without any systemic disease
  • Patients who have been informed about the duration, purpose and requirements of the study and who have signed the informed consent form voluntarily.

Exclusion criteria

  • Having a disease affecting general health that requires the application of prophylactic antimicrobial agents
  • Having a systemic viral, fungal or bacterial infection
  • Patients with acute or chronic maxillary sinusitis
  • Suspected or diagnosed pregnancy and nursing mothers
  • Patients with heart and vascular diseases
  • Patients with liver disease, haematological disease and neoplastic disease
  • Patients who have recently received anti-inflammatory therapy
  • Patients with chronic medication use (antihistamines, NSAIDs, steroids and antidepressants)
  • Patients predisposed to psychotic or psychopathic tendencies
  • Patients with rheumatic diseases, blood diseases, diabetes mellitus
  • Patients at cardiological risk of infective endocarditis
  • Patients under antibiotic pressure

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

49 participants in 2 patient groups

CGF
Experimental group
Description:
Participants received CGF after the operation on one side
Treatment:
Other: non-CGF
Other: Concentrated Growth Factor
non-CGF
No Intervention group
Description:
The other extraction socket is left empty

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems